525 related articles for article (PubMed ID: 27178746)
1. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay.
Aikin KJ; Southwell BG; Paquin RS; Rupert DJ; O'Donoghue AC; Betts KR; Lee PK
Res Social Adm Pharm; 2017; 13(2):378-388. PubMed ID: 27178746
[TBL] [Abstract][Full Text] [Related]
2. Effects of comparative claims in prescription drug direct-to-consumer advertising on consumer perceptions and recall.
O'Donoghue AC; Williams PA; Sullivan HW; Boudewyns V; Squire C; Willoughby JF
Soc Sci Med; 2014 Nov; 120():1-11. PubMed ID: 25194471
[TBL] [Abstract][Full Text] [Related]
3. Content analysis of false and misleading claims in television advertising for prescription and nonprescription drugs.
Faerber AE; Kreling DH
J Gen Intern Med; 2014 Jan; 29(1):110-8. PubMed ID: 24030427
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Including Quantitative Information on Multiple Endpoints in Direct-to-Consumer Prescription Drug Television Advertisements.
Sullivan HW; O'Donoghue AC; Lynch M; Johnson M; Davis C; Rupert DJ
Med Decis Making; 2019 Nov; 39(8):975-985. PubMed ID: 31583947
[No Abstract] [Full Text] [Related]
5. Visual presentations of efficacy data in direct-to-consumer prescription drug print and television advertisements: A randomized study.
Sullivan HW; O'Donoghue AC; Aikin KJ; Chowdhury D; Moultrie RR; Rupert DJ
Patient Educ Couns; 2016 May; 99(5):790-9. PubMed ID: 26749356
[TBL] [Abstract][Full Text] [Related]
6. Serious and actionable risks, plus disclosure: Investigating an alternative approach for presenting risk information in prescription drug television advertisements.
Betts KR; Boudewyns V; Aikin KJ; Squire C; Dolina S; Hayes JJ; Southwell BG
Res Social Adm Pharm; 2018 Oct; 14(10):951-963. PubMed ID: 28844621
[TBL] [Abstract][Full Text] [Related]
7. Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to FDA Guidelines.
Klara K; Kim J; Ross JS
J Gen Intern Med; 2018 May; 33(5):651-658. PubMed ID: 29484575
[TBL] [Abstract][Full Text] [Related]
8. Presenting efficacy information in direct-to-consumer prescription drug advertisements.
O'Donoghue AC; Sullivan HW; Aikin KJ; Chowdhury D; Moultrie RR; Rupert DJ
Patient Educ Couns; 2014 May; 95(2):271-80. PubMed ID: 24581929
[TBL] [Abstract][Full Text] [Related]
9. FDA direct-to-consumer advertising for prescription drugs: what are consumer preferences and response tendencies?
Khanfar N; Loudon D; Sircar-Ramsewak F
Health Mark Q; 2007; 24(1-2):77-91. PubMed ID: 19042521
[TBL] [Abstract][Full Text] [Related]
10. Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis.
Adams C
J Med Internet Res; 2016 Feb; 18(2):e33. PubMed ID: 26892749
[TBL] [Abstract][Full Text] [Related]
11. Communicating efficacy information based on composite scores in direct-to-consumer prescription drug advertising.
Williams PA; O'Donoghue AC; Sullivan HW; Willoughby JF; Squire C; Parvanta S; Betts KR
Patient Educ Couns; 2016 Apr; 99(4):583-590. PubMed ID: 26589655
[TBL] [Abstract][Full Text] [Related]
12. Direct-to-consumer drug advertisements on network television: an exploration of quantity, frequency, and placement.
Brownfield ED; Bernhardt JM; Phan JL; Williams MV; Parker RM
J Health Commun; 2004; 9(6):491-7. PubMed ID: 15764448
[TBL] [Abstract][Full Text] [Related]
13. Effects of image congruency on persuasiveness and recall in direct-to-consumer prescription drug advertising.
Kiernicki K; Helme DW
Health Mark Q; 2017; 34(4):284-301. PubMed ID: 29173108
[TBL] [Abstract][Full Text] [Related]
14. Consumer responses to framing statements preceding the major risk statement in prescription drug DTC TV ads.
Aikin KJ; Betts KR; Boudewyns V; Johnson M; Davis CN
Res Social Adm Pharm; 2020 Sep; 16(9):1237-1247. PubMed ID: 31838056
[TBL] [Abstract][Full Text] [Related]
15. An Updated Analysis of Direct-to-Consumer Television Advertisements for Prescription Drugs.
Applequist J; Ball JG
Ann Fam Med; 2018 May; 16(3):211-216. PubMed ID: 29760024
[TBL] [Abstract][Full Text] [Related]
16. Individual- and Ad-Level Predictors of Perceptions of Serious and Actionable Risks in Direct-to-Consumer Prescription Drug TV Advertising.
Aikin KJ; Boudewyns V; Betts KR; Southwell BG; Williams P
J Health Commun; 2019; 24(5):536-546. PubMed ID: 31253071
[TBL] [Abstract][Full Text] [Related]
17. The attitudes of consumers toward direct advertising of prescription drugs.
Morris LA; Brinberg D; Klimberg R; Rivera C; Millstein LG
Public Health Rep; 1986; 101(1):82-9. PubMed ID: 3080797
[TBL] [Abstract][Full Text] [Related]
18. Visual images of prescription drug benefits in direct-to-consumer television advertisements.
Sullivan HW; O'Donoghue AC; Lynch M; Johnson M; Davis C; Amoozegar JB; Rupert DJ
Patient Educ Couns; 2021 Sep; 104(9):2240-2249. PubMed ID: 33618970
[TBL] [Abstract][Full Text] [Related]
19. Selling Health to the Distracted: Consumer Responses to Source Credibility and Ad Appeal Type in a Direct-to-Consumer Advertisement.
Lemanski JL; Villegas J
Health Mark Q; 2015; 32(3):217-33. PubMed ID: 26368298
[TBL] [Abstract][Full Text] [Related]
20. Effect of presentation modality in direct-to-consumer (DTC) prescription drug television advertisements.
Wogalter MS; Shaver EF; Kalsher MJ
Appl Ergon; 2014 Sep; 45(5):1330-6. PubMed ID: 24377979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
